Evidence map›Paper›PMID 24730055›Full record

ArticleGenes, brain, and behavior2014

Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice.

J Brielmaier, J M Senerth, J L Silverman, P G Matteson, J H Millonig, E DiCicco-Bloom, J N Crawley

Open access · greenAbstract read
In one paragraph

Article in Genes, brain, and behavior, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism.Autism research : official journal of the International Society for Autism Research · 2019
    Article
  8. Review
  9. Article
  10. Review
  11. Serotonin neuron abnormalities in the BTBR mouse model of autism.Autism research : official journal of the International Society for Autism Research · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

J Brielmaier
J M Senerth
J L Silverman
P G Matteson
J H Millonig
E DiCicco-Bloom
J N Crawley
National Institute of Mental Health · USAdvanced Pharma · USJohnson University · US

Funding

Animal Models Of Neuropsychiatric DisordersZIAMH002179 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI CRAWLEY, JACQUELINE N · 2009 to 2012
$6.4M
Identification and Functional Assessment of Autism Susceptibility GenesR01MH076624 · NIMH · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI MILLONIG, JAMES H. · 2005 to 2009
$2.1M
Intramural NIH HHS Z99 MH999999Intramural NIH HHS ZIA MH002179NIMH NIH HHS R01 MH076624
6 · The paper itself

Abstract

Engrailed-2 (En2) is a homeobox transcription factor that regulates neurodevelopmental processes including neuronal connectivity and elaboration of monoaminergic neurons in the ventral hindbrain. We previously reported abnormalities in brain noradrenergic concentrations in En2 null mutant mice that were accompanied by increased immobility in the forced swim test, relevant to depression. An EN2 genetic polymorphism has been associated with autism spectrum disorders, and mice with a deletion in En2 display social abnormalities and cognitive deficits that may be relevant to multiple neuropsychiatric conditions. This study evaluated the ability of chronic treatment with desipramine (DMI), a selective norepinephrine (NE) reuptake inhibitor and classical antidepressant, to reverse behavioral abnormalities in En2−/− mice. Desipramine treatment significantly reduced immobility in the tail suspension and forced swim tests, restored sociability in the three-chambered social approach task and reversed impairments in contextual fear conditioning in En2−/− mice. Our findings indicate that modulation of brain noradrenergic systems rescues the depression-related phenotype in En2−/− mice and suggest new roles for NE in the pathophysiology of the social and cognitive deficits seen in neuropsychiatric disorders such as autism or schizophrenia.

Indexed as

Adrenergic Uptake InhibitorsAnimalsCognition DisordersDepressionDesipramineEngrailed 2 ProteinFearHomeodomain ProteinsLocomotionMiceMice, KnockoutNerve Tissue ProteinsSocial BehaviorAdrenergic Uptake InhibitorsDesipramineEngrailed 2 ProteinHomeodomain ProteinsNerve Tissue Proteins

Identifiers

PMID24730055
PMCPMC4004968
OpenAlexW1923414836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.